Electra Therapeutics, Inc. (NASDAQ:ETRA) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Matthew Fust Other companies: Neumora Therapeutics, Inc. (Director · Since at least Sep 14, 2023); Ultragenyx Pharmaceutical Inc. (Director · Since at least Jun 24, 2022); Atara Biotherapeutics, Inc. (Director · Since at least Jun 23, 2022); Crinetics Pharmaceuticals, Inc. (Director · Since at least Jun 17, 2022) | Director · Since at least Sep 18, 2026 |
| Carl L. Gordon Other companies: ADARx Pharmaceuticals, Inc. (Director · Since at least Sep 28, 2026); BlossomHill Therapeutics, Inc. (Director · Since at least Aug 10, 2026) | Director · Since at least Sep 21, 2026 |
| Nancy Stagliano Other companies: Pandion Therapeutics Inc (Director · Jul 16, 2020 – Apr 1, 2021 · Past) | Chairperson · Since at least Sep 18, 2026 |
| Adam Rosenthal | Director · Since at least Nov 5, 2026 |
| Beth Seidenberg | Director · Since at least Nov 4, 2026 |
| Chris Clark | Chief Financial Officer · Since at least Nov 4, 2026 |
| Christopher William Clark | Chief Financial Officer · Since at least Sep 18, 2026 |
| David J Tucker | Principal Accounting Officer · Since at least Sep 18, 2026 |
| Gary S. Koe | Chief Technical Officer · Since at least Sep 18, 2026 |
| Graham Parry | Chief Scientific Officer · Since at least Sep 18, 2026 |
| Kathy Dong | President, Chief Executive Officer and Director · Since at least Nov 4, 2026 |
| Kim-Hien Dao | Chief Medical Officer · Since at least Nov 5, 2026 |
| Quehuong Dong | President & CEO, Director · Since at least Sep 21, 2026 |
| Thomas Geninatti | Director · Since at least Nov 5, 2026 |